Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30395656

Nc1cc(=O)[nH]cn1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.38
HRH3 Q9Y5N1 2/20 0.38
PARP1 P09874 4/20 0.37
PDE2A O00408 1/20 0.36
GDA Q9Y2T3 1/20 0.34
GABRP O00591 3/20 0.33
GABRD O14764 3/20 0.33
GABRA1 P14867 3/20 0.33
GABRB1 P18505 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 3/20 0.33
GABRA2 P47869 3/20 0.33
GABRB2 P47870 3/20 0.33
GABRA4 P48169 3/20 0.33
GABRE P78334 3/20 0.33
GABRA6 Q16445 3/20 0.33
GABRG1 Q8N1C3 3/20 0.33
GABRG3 Q99928 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3628038 0.83
Trifluoroacetic Acid SCHEMBL27845057 0.74 CA2 (0.52) HRH4HRH3GABRPGABRDGABRA1
SCHEMBL29029022 0.73 PARP1 (0.40) PARP1PDE2AABL1RIN1SLC2A1
Trifluoroacetic Acid SCHEMBL30557181 0.70 ACVR1 (0.45) ABL1KDR
Trifluoroacetic Acid SCHEMBL30967251 0.68 HRH4 (0.43) HRH4HRH3GABRA1GABRA5GABRB2
Trifluoroacetic Acid SCHEMBL4627267 0.68 HRH4 (0.43) HRH4HRH3GABRA1GABRA5GABRB2
Trifluoroacetic Acid SCHEMBL27685394 0.68 GABRP (0.52) GABRPGABRDGABRA1GABRB1GABRG2
2-Aminopurine SCHEMBL27794196 0.68 HRH4 (0.38) HRH4HRH3GDAKDM4EALDH1A1
Adenine SCHEMBL9952923 0.67 MTAP (0.39) HRH4HRH3PARP1GDAALDH1A1
Adenine SCHEMBL28086748 0.67 MTAP (0.39) HRH4HRH3PARP1GDAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12558357-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents MERCK SHARP & DOHME LLC (US) 2026-02-24 US claimed
US-11648250-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents MERCK SHARP & DOHME LLC (US) 2023-05-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11648250-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents ACIN1, REV1, NFATC1 HRH4 3871/4885HRH3 3444/4885PARP1 201/4885
US-12558357-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents ACIN1, CD4, CCR8 HRH4 1244/4885HRH3 1447/4885PARP1 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.